Current Neuro-Oncology
Volume
27 Number 24
31 August 2025
Home > Publications > Current Neuro-Oncology > Volume 27, Year 2025 > Number 24, 31 August
Drummond KJ, Spiteri M, Cain SA, Jones J, Shaya S, Topp M, Lu T,
Tobler R, Valkovic AL, Moore Z, Fatunla OE, Kriel J, Moffet JJD,
McAlpine H, Rosier M, Guan H, Dimou J, Schadewaldt V,
Roberts-Thomson S, McArdle D, Lui E, Voelker-Albert M, di Sanzo S,
Nijagal B, Narayana VK, Mitchell CB, Vissers JHA, Grimmond S,
Rosenthal MA, Palmer LM, Best SA, Freytag S, Whittle
JR.
Perioperative IDH
inhibition in treatment-naive
IDH-mutant glioma: a pilot trial.
Nat
Med. 2025 Aug 21. doi:
10.1038/s41591-025-03884-4. PMID:
40841487. Interventional study. ˍ
ClinicalTrials.gov
ID: NCT05577416.
Kang Z, Li S, Wang L, Chen Q, Hu W, Lei T, Mao Y, Zhang J, Xiang
X, Wang Q, He Z, Sun T, Wang Y, Huang M, Zhang R, Chen F, Li W.
SYHA1813, A VEGFR and CSF1R Inhibitor,
in Patients With Recurrent High-Grade Gliomas: A Multicenter,
Open-Label Phase I Study.
Ann
Clin Transl Neurol. 2025 Aug 22. doi:
10.1002/acn3.70166. PMID:
40847460. Interventional study. ˍ
ChiCTR.org.cn
ID: ChiCTR2100045380.
Kawabata S, Goto H, Narita Y, Furuse M, Nonoguchi N, Shidoh-Kazuki
R, Eza K, Hirose K, Ohno M, Kondo N, Suzuki M, Tanaka H, Ono K,
Nihei K, Wanibuchi M, Miyatake SI.
Extended
follow-up of recurrent glioblastoma patients treated with boron
neutron capture therapy (BNCT): Long-term survival from a Phase II
trial (JG002) using Cyclotron Neutron Source and
Boronophenylalanine.
Appl
Radiat Isot. 2025 Aug 22;226:112118. doi:
10.1016/j.apradiso.2025.112118. PMID:
40865370. Interventional
study˰ ˍ
Maffezzini M, Musio S, Di Ianni N, Rumolo A, Patanè M,
Galluzzo A, Sambruni I, Berlendis A, Aquino D, Baso G, Zingarelli
M, Facciolla M, Maddaloni L, Valentino R, Paterra R, Agistri F,
Farinotti M, Mattei L, Coluccia P, Acerbi F, DiMeco F, Pollo B,
Silvani A, Eoli M, Traversari C, Montagna D, Pellegatta S.
Polyclonal expansion of functional
tumor-reactive lymphocytes infiltrating glioblastoma for
personalized cell therapy.
Nat
Commun. 2025 Aug 25;16(1):7279. doi:
10.1038/s41467-025-62263-2. PMID:
40855052. Translational
study. ˍ
Daftari M, Ramsoomair CK, Aaronson D, Seetharam D, Andreae EA,
Wright L, Han S, Chandar J, Lu V, Govindarajan V, Ivan ME, Komotar
RJ, de la Fuente M, Shah AH.
Synergistic
Treatment with Antiretrovirals and Laser Interstitial Thermal
ThErapy (STARLITE) for unresectable glioblastoma: A phase 1 study
protocol.
PLoS
One. 2025 Aug 28;20(8):e0328204. doi:
10.1371/journal.pone.0328204. PMID:
40875628. Interventional study protocol. ˍ
Lee A, Cole BL, Ojemann J, Kittle D, Perry J, Parrish-Novak J,
Miller DM, Hansen S, Harrington K, Ishak L, Gombotz C, Starr K,
Poliachik SL, Leary SES.
Phase 1 and
expanded imaging study of tozuleristide in patients with pediatric
primary central nervous system tumors.
J
Neurosurg Pediatr. 2025 Aug 29:1-11. doi:
10.3171/2025.5.PEDS24630. PMID:
40882241. Interventional study˰
ˍ